BNP Paribas Financial Markets’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-10,850
| Closed | -$374K | – | 3574 |
|
|
2020
Q3 | $374K | Buy |
10,850
+1,172
| +12% | +$40.4K | ﹤0.01% | 1808 |
|
|
2020
Q2 | $162K | Sell |
9,678
-17,418
| -64% | -$291K | ﹤0.01% | 1973 |
|
|
2020
Q1 | $391K | Buy |
27,096
+20,851
| +334% | +$301K | ﹤0.01% | 1923 |
|
|
2019
Q4 | $209K | Sell |
6,245
-1,708
| -21% | -$57.2K | ﹤0.01% | 2297 |
|
|
2019
Q3 | $167K | Buy |
7,953
+2,099
| +36% | +$44K | ﹤0.01% | 2237 |
|
|
2019
Q2 | $122K | Sell |
5,854
-4,203
| -42% | -$87.5K | ﹤0.01% | 2312 |
|
|
2019
Q1 | $225K | Buy |
10,057
+9,052
| +901% | +$202K | ﹤0.01% | 2062 |
|
|
2018
Q4 | $24K | Sell |
1,005
-1,467
| -59% | -$35.1K | ﹤0.01% | 2369 |
|
|
2018
Q3 | $67.4K | Buy |
2,472
+199
| +9% | +$5.43K | ﹤0.01% | 2280 |
|
|
2018
Q2 | $61.1K | Sell |
2,273
-5,220
| -70% | -$140K | ﹤0.01% | 2393 |
|
|
2018
Q1 | $239K | Buy |
7,493
+214
| +3% | +$6.81K | ﹤0.01% | 2147 |
|
|
2017
Q4 | $275K | Buy |
7,279
+2,881
| +66% | +$109K | ﹤0.01% | 2169 |
|
|
2017
Q3 | $109K | Buy |
4,398
+386
| +10% | +$9.57K | ﹤0.01% | 2363 |
|
|
2017
Q2 | $82.5K | Buy |
4,012
+3,561
| +790% | +$73.2K | ﹤0.01% | 2477 |
|
|
2017
Q1 | $9.8K | Sell |
451
-1,350
| -75% | -$29.3K | ﹤0.01% | 2654 |
|
|
2016
Q4 | $36.8K | Sell |
1,801
-371
| -17% | -$7.59K | ﹤0.01% | 2500 |
|
|
2016
Q3 | $32.6K | Buy |
2,172
+1,070
| +97% | +$16.1K | ﹤0.01% | 2641 |
|
|
2016
Q2 | $11.9K | Buy |
1,102
+1,097
| +21,940% | +$11.9K | ﹤0.01% | 2825 |
|
|
2016
Q1 | $68 | Sell |
5
-2,277
| -100% | -$31K | ﹤0.01% | 2633 |
|
|
2015
Q4 | $42.1K | Buy |
2,282
+217
| +11% | +$4K | ﹤0.01% | 2929 |
|
|
2015
Q3 | $52.3K | Buy |
+2,065
| New | +$52.3K | ﹤0.01% | 2828 |
|